Heidi B Capozzi bought $4,589 of CVS
EVP and Chief People Officer at CVS HEALTH Corp. 80 shares at an average of $57.36, traded Sep 9, 2024, filed Oct 14, 2025.
Score components
- +15RoleOfficer
- 0Trade size$5k at market
- +10Relative to holdingsHoldings up 1600%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +0.3%, 3m +2.1%, 6m -1.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000064803-25-000031, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 9, 2024 | POpen-market purchase Common Stockindirect: By Trust | +35 | $56.47 | $1,976 | 40 | Oct 14, 2025 |
| Oct 2, 2024 | POpen-market purchase Common Stockindirect: By Trust | +10 | $62.24 | $622 | 50 | Oct 14, 2025 |
| Oct 23, 2024 | POpen-market purchase Common Stockindirect: By Trust | +35 | $56.85 | $1,990 | 85 | Oct 14, 2025 |
Related signals
Other insiders at CVS HEALTH Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 58Moderate | CVS HEALTH Corp | Larry Robbins director | $317M 3,372,000 shares | -41% | |
| 68Notable | CVS HEALTH Corp | Tilak Mandadi EVP, Chief Exp & Tech Officer | $6.2M 69,551 shares | -87% | |
| 27Weak | CVSbuy CVS HEALTH Corp | Steven H Nelson EVP and President, Aetna | $1,289 24 shares | - | |
| 43Moderate | CVSsell CVS HEALTH Corp | Anne A. Finucane director | $533k 7,500 shares | -25% | |
| 28Weak | CVSbuy CVS HEALTH Corp | Guy P Sansone director | $100k 1,570 shares | +15% | |
| 50Moderate | CVSsell CVS HEALTH Corp | Larry Robbins director | $254M 3,750,000 shares | -31% | |
| 28Weak | CVSsell CVS HEALTH Corp | James David Clark SVP, Cont & Chief Acct Officer | $498k 7,513 shares | -47% | |
| 50Moderate | CVSbuy CVS HEALTH Corp | Michael F Mahoney director | $2.0M 30,000 shares | +321% | |
| 69Notable | CVS HEALTH Corp | Michael F Mahoney director | $500k 9,181 shares | +5246% | |
| 48Moderate | CVS HEALTH Corp | Edward J Ludwig director | $54k 1,000 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.